Serum Klotho: Relation to Fibroblast Growth Factor-23 and Other Regulators of Phosphate Metabolism in Children with Chronic Kidney Disease

Publisher： Karger

E-ISSN： 2235-3186|129|4|293-299

ISSN： 1660-8151

Source： Nephron, Vol.129, Iss.4, 2015-03, pp. : 293-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)

By  

Nephron, Vol. 134, Iss. 4, 2016-07 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 in Chronic Kidney Disease: Bridging the Gap between Bone Mineral Metabolism and Left Ventricular Hypertrophy

By  

Blood Purification, Vol. 31, Iss. 1-3, 2010-12 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Cardiac Changes and Their Association with Fetuin-A and Fibroblast Growth Factor-23 in Children with Chronic Kidney Disease

By  

Nephron, Vol. 136, Iss. 3, 2017-04 ,pp. : 233-242

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-10 ,pp. : 276-283

Karger

Access to resources Recommend Favorite

Neutrophil Gelatinase-Associated Lipocalin, Fibroblast Growth Factor 23, and Soluble Klotho in Long-Term Kidney Donors

By  

Nephron Extra, Vol. 6, Iss. 3, 2016-01 ,pp. : 31-39

Karger

Access to resources Recommend Favorite